Dalfampridine ER

Drug Details

Dalfampridine, marketed under the brand name Ampyra, is an oral medication specifically designed to enhance walking abilities in individuals diagnosed with multiple sclerosis (MS). This drug functions as a potassium channel blocker, which plays a crucial role in improving nerve conduction. In MS, nerve damage can lead to impaired function due to excess potassium exiting nerve cells through potassium channels. By blocking these channels, dalfampridine helps to improve nerve communication, thus aiding in walking. It is typically taken as a tablet twice daily. While using Ampyra, some individuals may experience side effects such as urinary tract infections, insomnia, or dizziness. Always consult a healthcare professional before starting any medication to ensure it is safe and appropriate for your condition.